Lyubarova Radmila, Boden William E, Fein Steven A, Schulman-Marcus Joshua, Torosoff Mikhail
Division of Cardiology, Albany Medical College, 47 New Scotland Avenue, MC44, Albany, NY, 12208, USA.
Clinical Trials Network, VA New England Healthcare System, Boston University School of Medicine, Boston, MA, USA.
J Echocardiogr. 2018 Jun;16(2):65-71. doi: 10.1007/s12574-017-0357-1. Epub 2017 Nov 7.
Transthoracic echocardiography (TTE) has been used to assess coronary sinus blood flow (CSBF), which reflects total coronary arterial blood flow. Successful angioplasty is expected to improve coronary arterial blood flow. Changes in CSBF after percutaneous coronary intervention (PCI), as assessed by TTE, have not been systematically evaluated.
TTE can be utilized to reflect increased CSBF after a successful, clinically indicated PCI.
The study cohort included 31 patients (18 females, 62 ± 11 years old) referred for diagnostic cardiac catheterization for suspected coronary artery disease and possible PCI, when clinically indicated. All performed PCIs were successful, with good angiographic outcome. CSBF per cardiac cycle (mL/beat) was measured using transthoracic two-dimensional and Doppler flow imaging as the product of coronary sinus (CS) area and CS flow time-velocity integral. CSBF per minute (mL/min) was calculated as the product of heart rate and CSBF per cardiac cycle. In each patient, CSBF was assessed prospectively, before and after cardiac catheterization with and without clinically indicated PCI. Within- and between-group differences in CSBF before and after PCI were assessed using repeated measures analysis of variance.
Technically adequate CSBF measurements were obtained in 24 patients (77%). In patients who did not undergo PCI, there was no significant change in CSBF (278.1 ± 344.1 versus 342.7 ± 248.5, p = 0.36). By contrast, among patients who underwent PCI, CSBF increased significantly (254.3 ± 194.7 versus 618.3 ± 358.5 mL/min, p < 0.01, p-interaction = 0.03). Other hemodynamic and echocardiographic parameters did not change significantly before and after cardiac catheterization in either treatment group.
Transthoracic echocardiographic assessment can be employed to document CSBF changes after angioplasty. Future studies are needed to explore the clinical utility of this noninvasive metric.
经胸超声心动图(TTE)已被用于评估冠状静脉窦血流(CSBF),其反映了冠状动脉总血流量。成功的血管成形术有望改善冠状动脉血流量。经TTE评估,经皮冠状动脉介入治疗(PCI)后CSBF的变化尚未得到系统评估。
TTE可用于反映成功的、临床指征性PCI后CSBF的增加。
研究队列包括31例患者(18例女性,62±11岁),因疑似冠状动脉疾病和临床指征可能进行PCI而接受诊断性心导管检查。所有进行的PCI均成功,血管造影结果良好。每个心动周期的CSBF(mL/搏)使用经胸二维和多普勒血流成像测量,为冠状静脉窦(CS)面积与CS血流时间速度积分的乘积。每分钟CSBF(mL/min)计算为心率与每个心动周期CSBF的乘积。在每位患者中,在有或无临床指征性PCI的心导管检查前后,前瞻性评估CSBF。使用重复测量方差分析评估PCI前后CSBF的组内和组间差异。
24例患者(77%)获得了技术上足够的CSBF测量值。未接受PCI的患者CSBF无显著变化(278.1±344.1与342.7±248.5,p = 0.36)。相比之下,接受PCI的患者中,CSBF显著增加(254.3±194.7与618.3±358.5 mL/min,p < 0.01,p交互作用 = 0.03)。两个治疗组在心导管检查前后其他血流动力学和超声心动图参数均无显著变化。
经胸超声心动图评估可用于记录血管成形术后CSBF的变化。未来需要研究探索这种非侵入性指标的临床实用性。